Mucus Relief D Tablet, Multilayer, Extended Release
Product Images NDC 0363-8708

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief D (NDC 0363-8708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreen Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Mucus Relief D (Image 01)

Mucus Relief D (Image 01)
This is a description of Mucinex® D, a medication available in extended-release bi-layer tablets that contain Guaifenesin (an expectorant) and Pseudoephedrine Hydrochloride (a nasal decongestant). The tablets provide 12-hour relief by clearing nasal/sinus congestion, thinning & loosening mucus, and offering immediate & extended release benefits. The active ingredients help to relieve symptoms such as nasal congestion due to common colds, hay fever, or upper respiratory allergies. However, there are warnings for individuals with specific conditions like heart disease, high blood pressure, thyroid disease, diabetes, etc. The text also mentions dosage instructions, potential side effects like nervousness, dizziness, and guidelines for pregnant or breastfeeding women. It advises keeping the medication out of reach of children and provides information on inactive ingredients. The product is manufactured or distributed by REHealth US LLC and bears the registered trademark Mucinex®. For additional questions or comments, a contact number is provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.